Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BI-3812 is an inhibitor of BCL6. Which inhibiting the BTB domain of BCL6 (IC50: 3 nM). BI-3812 also has antitumor activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 112.00 | |
2 mg | In stock | $ 165.00 | |
5 mg | In stock | $ 263.00 | |
10 mg | In stock | $ 447.00 | |
25 mg | In stock | $ 739.00 | |
50 mg | In stock | $ 987.00 | |
100 mg | In stock | $ 1,390.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 323.00 |
Description | BI-3812 is an inhibitor of BCL6. Which inhibiting the BTB domain of BCL6 (IC50: 3 nM). BI-3812 also has antitumor activity. |
Targets&IC50 | BCL6 BTB:≤3 nM (IC50) |
In vivo | BI-3812 is a BCL6 inhibitor, with an IC50 of ≤3 nM. BI-3812 shows an IC50 of 40 nM for the cellular BCL6[1]. |
Molecular Weight | 558.03 |
Formula | C26H32ClN7O5 |
CAS No. | 2166387-64-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 19.83 mg/mL(35.54 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BI-3812 2166387-64-8 Apoptosis BCL BI 3812 Inhibitor inhibit Bcl-2 Family BI3812 inhibitor